151 related articles for article (PubMed ID: 12813475)
21. Forebrain D1 function and sensorimotor gating in rats: effects of D1 blockade, frontal lesions and dopamine denervation.
Swerdlow NR; Shoemaker JM; Kuczenski R; Bongiovanni MJ; Neary AC; Tochen LS; Saint Marie RL
Neurosci Lett; 2006 Jul; 402(1-2):40-5. PubMed ID: 16644125
[TBL] [Abstract][Full Text] [Related]
22. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function.
Heidenreich BA; Mitrovic I; Battaglia G; Napier TC
Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253
[TBL] [Abstract][Full Text] [Related]
23. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
Burger LY; Martin-Iverson MT
Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
[TBL] [Abstract][Full Text] [Related]
24. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
25. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.
Okubo Y; Suhara T; Suzuki K; Kobayashi K; Inoue O; Terasaki O; Someya Y; Sassa T; Sudo Y; Matsushima E; Iyo M; Tateno Y; Toru M
Nature; 1997 Feb; 385(6617):634-6. PubMed ID: 9024661
[TBL] [Abstract][Full Text] [Related]
26. First D1-like receptor PET imaging of the rat and primate kidney: implications for human disease monitoring.
Granda ML; Schroeder FA; Borra RH; Schauer N; Aisaborhale E; Guimaraes AR; Hooker JM
Am J Physiol Renal Physiol; 2014 Jul; 307(1):F116-21. PubMed ID: 24808534
[TBL] [Abstract][Full Text] [Related]
27. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
28. Identification of age-related changes of dopamine D1-like receptors in the rat cerebellar cortex.
Ricci A; Zaccheo D; Amenta F
Synapse; 1995 Sep; 21(1):37-44. PubMed ID: 8525460
[TBL] [Abstract][Full Text] [Related]
29. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
[TBL] [Abstract][Full Text] [Related]
30. Altered prefrontal dopaminergic function in chronic recreational ketamine users.
Narendran R; Frankle WG; Keefe R; Gil R; Martinez D; Slifstein M; Kegeles LS; Talbot PS; Huang Y; Hwang DR; Khenissi L; Cooper TB; Laruelle M; Abi-Dargham A
Am J Psychiatry; 2005 Dec; 162(12):2352-9. PubMed ID: 16330601
[TBL] [Abstract][Full Text] [Related]
31. Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.
Karimi M; Moerlein SM; Videen TO; Su Y; Flores HP; Perlmutter JS
Mov Disord; 2013 Dec; 28(14):2002-6. PubMed ID: 24151192
[TBL] [Abstract][Full Text] [Related]
32. Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks.
Dougherty DD; Bonab AA; Ottowitz WE; Livni E; Alpert NM; Rauch SL; Fava M; Fischman AJ
Depress Anxiety; 2006; 23(3):175-7. PubMed ID: 16528700
[TBL] [Abstract][Full Text] [Related]
33. NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists.
Andersen PH; Grønvald FC; Hohlweg R; Hansen LB; Guddal E; Braestrup C; Nielsen EB
Eur J Pharmacol; 1992 Aug; 219(1):45-52. PubMed ID: 1397049
[TBL] [Abstract][Full Text] [Related]
34. Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.
Cropley VL; Fujita M; Bara-Jimenez W; Brown AK; Zhang XY; Sangare J; Herscovitch P; Pike VW; Hallett M; Nathan PJ; Innis RB
Psychiatry Res; 2008 Jul; 163(2):171-82. PubMed ID: 18504119
[TBL] [Abstract][Full Text] [Related]
35. A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain.
Chou YH; Karlsson P; Halldin C; Olsson H; Farde L
Psychopharmacology (Berl); 1999 Sep; 146(2):220-7. PubMed ID: 10525759
[TBL] [Abstract][Full Text] [Related]
36. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.
Abi-Dargham A; Moore H
Neuroscientist; 2003 Oct; 9(5):404-16. PubMed ID: 14580124
[TBL] [Abstract][Full Text] [Related]
37. An increase in [3H]SCH23390 binding in the cerebral cortex of postmortem brains of chronic schizophrenics.
Domyo T; Kurumaji A; Toru M
J Neural Transm (Vienna); 2001; 108(12):1475-84. PubMed ID: 11810409
[TBL] [Abstract][Full Text] [Related]
38. Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study.
Chou YH; Halldin C; Farde L
Psychopharmacology (Berl); 2006 Mar; 185(1):29-35. PubMed ID: 16395606
[TBL] [Abstract][Full Text] [Related]
39. The dopamine D₁ receptor agonist (S)-[¹¹C]N-methyl-NNC 01-0259 is not sensitive to changes in dopamine concentration--a positron emission tomography examination in the monkey brain.
Finnema SJ; Bang-Andersen B; Jørgensen M; Christoffersen CT; Gulyás B; Wikström HV; Farde L; Halldin C
Synapse; 2013 Sep; 67(9):586-95. PubMed ID: 23504964
[TBL] [Abstract][Full Text] [Related]
40. MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors.
Wedzony K; Klimek V; Gołembiowska K
Brain Res; 1993 Sep; 622(1-2):325-9. PubMed ID: 8242376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
